QC
AMGN icon

QCM Cayman’s Amgen AMGN Stock Holding History

QCM Cayman’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-9,000
Closed -$1.48M – 153
2017
Q1 		$1.48M Buy
+9,000
New +$1.5M 0.28% 85
2016
Q4 		– Sell
-1,400
Closed -$234K – 138
2016
Q3 		$234K Sell
1,400
-300
-18% -$50.7K 0.26% 122
2016
Q2 		$259K Buy
+1,700
New +$264K 0.11% 162
2016
Q1 		– Sell
-10,100
Closed -$1.64M – 197
2015
Q4 		$1.64M Buy
10,100
+5,500
+120% +$865K 1.36% 16
2015
Q3 		$636K Buy
+4,600
New +$725K 0.21% 47
2015
Q2 		– Sell
-1,600
Closed -$256K – 176
2015
Q1 		$256K Sell
1,600
-3,200
-67% -$504K 0.14% 133
2014
Q4 		$765K Buy
+4,800
New +$748K 0.32% 51
2014
Q3 		– Sell
-5,500
Closed -$651K – 196
2014
Q2 		$651K Buy
5,500
+2,400
+77% +$278K 0.31% 59
2014
Q1 		$382K Buy
+3,100
New +$376K 0.09% 135
2013
Q4 		– Sell
-7,200
Closed -$806K – 87
2013
Q3 		$806K Buy
+7,200
New +$781K 0.49% 44

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

QCM Cayman's AMGN Position: Q1 2021 in Review

QCM Cayman sold out of Amgen (AMGN) in Q1 2021, closing a stake of 1,178 shares — an estimated $271K sold.

QCM Cayman first reported a position in AMGN in Q2 2014 and held it in 8 quarters. The position peaked at $693K in Q4 2015. 2,219 funds tracked by Wall St. Rank hold AMGN as of Q1 2021.

  • QCM Cayman reported no remaining Amgen position as of Q1 2021 after selling out during the quarter.
  • QCM Cayman sold 1,178 Amgen shares in Q1 2021, an estimated $271K.
  • QCM Cayman first reported a position in Amgen in Q2 2014 and held it in 8 quarters.
  • QCM Cayman's Amgen position peaked at $693K in Q4 2015.
  • 2,219 funds tracked by Wall St. Rank held Amgen as of Q1 2021.

Based on QCM Cayman's 13F filing for Q1 2021, filed 17 May 2021.